GENEVA, June 19 -- DECIPHERA PHARMACEUTICALS, LLC (200 Smith StreetWaltham, Massachusetts 02451) filed a patent application (PCT/US2024/058998) for "FORMULATIONS OF VIMSELTINIB" on Dec 06, 2024. With publication no. WO/2025/122952, the details related to the patent application was published on Jun 12, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): HAMED, Ehab (200 Smith StreetWaltham, Massachusetts 02451)
Abstract:
Described herein, in part, are pharmaceutically acceptable formulations comprising a compound represented by Formula (I) and methods of preparing and using the formulations:
...